JG 8121 Pill - yellow capsule/oblong, 22mm
Generic Name: cobicistat/darunavir/emtricitabine/tenofovir alafenamide
Pill with imprint JG 8121 is Yellow, Capsule/Oblong and has been identified as Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg. It is supplied by Janssen Pharmaceuticals, Inc.
Symtuza is used in the treatment of HIV Infection and belongs to the drug class antiviral combinations. Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for JG 8121
Symtuza
- Generic Name
- cobicistat/darunavir/emtricitabine/tenofovir alafenamide
- Imprint
- JG 8121
- Strength
- cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg
- Color
- Yellow
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 59676-0800
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Patient resources
Professional resources
- Symtuza prescribing information
- Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (AHFS Monograph)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
